Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

• Conditions: Neurofibromatosis Type 1

• Registration Number: NCT02078401
• Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Brief Summary

The goal of this project is to get more insight into the (neuro)ophthalmological characteristics of children with neurofibromatosis type 1. This way investigators would like to update the current guidelines for follow up and treatment of optic pathway gliomas. Clinical findings will be compared with the results of Optical coherence tomography (OCT) and MRI (magnetic resonance imaging).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-02-26
• Study First Submitted QC: 2014-02-28
• Study First Posted: 2014-03-05
• Study Start: 2014-04
• Status Verified: 2014-07
• Last Update Submitted: 2014-07-01
• Last Update Posted: 2014-07-02
• Primary Completion: 2014-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• neurofibromatosis type 1

Exclusion Criteria

• no neurofibromatosis type 1

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual acuity	childhood (0 to 18y)
Presence of optic pathway glioma	childhood (0 to18y)

Trial Locations

Locations (1)

University Hospitals Leuven; 🇧🇪 Leuven, Belgium